Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.

Loft, M, Lok, SW, De Boer, RH, Malik, L, Greenberg, S, Yeo, B, Anton, A, Nott, LM, Richardson, GE, COLLINS, IAN, Torres, J, Barnett, FS, Devitt, BA, Gibbs, P and Gately, L 2020, Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer., JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15.


Title Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer.
Author(s) Loft, M
Lok, SW
De Boer, RH
Malik, L
Greenberg, S
Yeo, B
Anton, A
Nott, LM
Richardson, GE
COLLINS, IANORCID iD for COLLINS, IAN orcid.org/0000-0001-6936-0942
Torres, J
Barnett, FS
Devitt, BA
Gibbs, P
Gately, L
Journal name JOURNAL OF CLINICAL ONCOLOGY
Volume number 38
Issue number 15
Total pages 3
Publisher LIPPINCOTT WILLIAMS & WILKINS
Place of publication ELECTR NETWORK
Publication date 2020-05-20
ISSN 0732-183X
1527-7755
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Oncology
Language eng
Indigenous content off
Field of Research 1103 Clinical Sciences
1112 Oncology and Carcinogenesis
HERDC Research category C2 Other contribution to refereed journal
Persistent URL http://hdl.handle.net/10536/DRO/DU:30138166

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 5 Abstract Views  -  Detailed Statistics
Created: Fri, 05 Jun 2020, 15:05:16 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.